Multiple sclerosis damages the brain by stripping away the protective coating around nerve fibers, a process called demyelination. Over time, this leads to shrinking of brain tissue, disrupted signaling between neurons, and cognitive problems that affect 40 to 65 percent of people with MS. The damage isn’t limited to one area or one type of tissue. It hits both the wiring (white matter) and the processing centers (gray matter), producing a wide range of neurological symptoms.
How the Immune System Attacks Brain Tissue
MS is an autoimmune disease. The immune system, which normally fights infections, mistakenly identifies components of the brain and spinal cord as threats. Immune cells cross the blood-brain barrier, a tightly sealed layer of cells that normally keeps the brain shielded from the rest of the body’s immune activity. Once inside, these cells target myelin, the fatty insulating layer that wraps around nerve fibers like the coating on an electrical wire.
Myelin is produced by specialized cells called oligodendrocytes. In MS, the immune attack damages both the myelin itself and these myelin-producing cells. Without intact myelin, electrical signals traveling along nerve fibers slow down, become distorted, or stop entirely. This is why MS symptoms can appear suddenly and affect almost any function the brain controls, from vision to movement to thinking.
The damage doesn’t stop at myelin. As the disease progresses, the nerve fibers underneath (called axons) can also be injured or severed. Once an axon is destroyed, that connection is permanently lost. This shift from reversible myelin damage to irreversible nerve fiber loss is a major reason MS can become progressively disabling over time.
White Matter, Gray Matter, and Brain Shrinkage
Early descriptions of MS focused on white matter, the brain’s network of insulated nerve fibers connecting different regions. But research has made clear that gray matter, where the actual nerve cell bodies live and process information, shrinks significantly too. MRI studies show that people with MS have measurably smaller volumes of both gray and white matter compared to people without the disease.
The distinction matters because each type of tissue loss produces different symptoms. White matter volume is the strongest predictor of mental processing speed and working memory, your ability to hold and manipulate information in real time. Gray matter volume, on the other hand, better predicts verbal memory (recalling words, stories, or lists) and behavioral changes like euphoria or disinhibition. Together, these losses account for more of the cognitive decline in MS than the visible lesions alone.
People with MS lose brain volume at roughly 0.5% per year, compared to about 0.27% per year in healthy adults. That may sound small, but the difference compounds over years and decades, accelerating cognitive and physical decline well beyond what normal aging would produce.
What MS Lesions Look Like on MRI
Brain MRI is the primary tool for diagnosing and monitoring MS. The scans reveal lesions, areas of damage scattered throughout the brain and spinal cord. Not all lesions are the same, and their appearance tells neurologists a lot about what’s happening.
- Active inflammatory lesions light up when a contrast dye called gadolinium is injected during the scan. This enhancement indicates a fresh breach in the blood-brain barrier, meaning the immune system is actively attacking at that spot. The enhancement typically lasts about one month, starting as a solid bright area and sometimes evolving into a ring pattern.
- Chronic lesions are older areas of damage where the initial inflammation and swelling have subsided. They still appear as bright spots on certain MRI sequences but no longer enhance with contrast dye, meaning the active attack has ended even though the scar remains.
- Chronic active lesions are particularly concerning. These have a persistent rim of activated immune cells at their edges, slowly expanding outward and continuing to destroy tissue. They represent smoldering, ongoing damage even during periods when a person may feel stable.
The 2024 revisions to the McDonald diagnostic criteria, the standard framework for diagnosing MS, now recognize the optic nerve as a fifth anatomical location where lesions can count toward a diagnosis. Newer MRI markers, including the “central vein sign” (a small vein visible in the center of a lesion) and paramagnetic rim lesions, can help distinguish MS lesions from similar-looking spots caused by migraines, aging, or other conditions.
Cognitive Effects of MS
Between 40 and 65 percent of people with MS experience some degree of cognitive impairment. This isn’t the dramatic memory loss associated with dementia. Instead, it tends to affect specific mental functions in ways that are subtle but disruptive to daily life.
The most commonly affected abilities include processing speed (how quickly you can take in and respond to information), working memory (holding a phone number in your head while you dial it), episodic memory (recalling a conversation from yesterday or items on a shopping list), and divided attention (juggling multiple tasks at once). Many people describe it as a mental fog: thoughts feel slower, multitasking becomes harder, and retrieving the right word takes longer than it used to.
These cognitive changes can appear early in the disease, sometimes even before a formal diagnosis. They don’t always track neatly with physical disability. Someone who walks without difficulty may still struggle with concentration at work, while someone with significant mobility problems may have sharp cognition. The cognitive effects correlate more closely with overall brain volume loss than with any single lesion or relapse.
Why the Brain Struggles to Repair Itself
The brain does have a natural repair mechanism for myelin damage. After an immune attack, the body can generate new oligodendrocytes from a pool of precursor cells already present in the brain. These new cells can wrap fresh myelin around stripped nerve fibers, a process called remyelination. In the early stages of MS, this repair process works reasonably well, which is why many people recover fully or nearly fully from early relapses.
Over time, though, remyelination becomes increasingly incomplete. The precursor cells that should mature into new myelin-producing oligodendrocytes get stuck in an immature state, unable to complete their development. The lesion environment itself becomes hostile to repair: scar tissue builds up, chemical signals that would normally guide precursor cells to the damage site are disrupted, and in some cases, molecules that actively repel these repair cells accumulate around lesions.
Chronic inflammation plays a central role in this failure. When immune activation persists at the edges of lesions, it creates conditions that block regeneration rather than support it. The result is a widening gap between damage and repair. Each new attack leaves a little more permanent injury behind, and the brain’s compensatory capacity gradually diminishes. This is why early and effective treatment aimed at reducing new immune attacks is so important: it preserves the brain’s ability to heal while that ability still exists.
How Brain Damage Translates to Symptoms
Because MS lesions can appear almost anywhere in the brain and spinal cord, the symptoms vary enormously from person to person. A lesion near the brain’s visual processing area might cause blurred or double vision. One in the cerebellum might cause balance problems or tremor. Lesions along the pathways controlling movement can produce weakness, stiffness, or coordination difficulties.
Fatigue, one of the most common and debilitating MS symptoms, is partly a brain phenomenon. When nerve signals must travel through damaged or poorly insulated pathways, the brain works harder to accomplish tasks that used to be effortless. This extra neural effort contributes to the profound, disproportionate tiredness that many people with MS describe as unlike ordinary fatigue.
Mood and personality changes also trace back to brain involvement. Depression occurs in roughly half of people with MS over their lifetime, driven by both the psychological burden of living with a chronic illness and direct damage to brain circuits involved in emotional regulation. The gray matter losses that predict disinhibition and euphoria suggest that some behavioral changes in MS are neurological symptoms, not just emotional reactions to the diagnosis.